The global dermal fillers market size was estimated to be USD 6.42 billion in 2023 and is expected to reach at USD 15.5 billion by 2033 with a CAGR of 8.37% during the forecast period 2023-2033. Increasing prevalence of early skin aging, growing demand for minimal invasive surgical procedure, rising demand for dermal fillers procedure, surge in geriatric population, increasing technological advancement in medical aesthetic products, rising self-awareness among young population regarding physical appearance, growing research & development activities, and surge in launch of innovative products by leading market players are some of the key factors boosting the market growth.
Surge in launch of innovative products by leading market players is predicted to boost the market growth during the forecast period. For instance, in February 2022, Medical aesthetics company, Merz Aesthetics, has introduced the Radiesse (+) Lidocaine injectable implant designed for deep injections to address the issue of moderate to severe loss of jawline contour in adults aged 21 and above.
By Type, Hyaluronic acid (HA) was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the growing adoption of dermal fillers by all age groups, increasing awareness about benefits of non-invasive aesthetic procedure, and rising approvals of technologically advanced products by regulatory bodies. For instance, in May 2020, Galderma, a pharmaceutical and dermatology company, has received approval from the U.S. Food & Drug Administration (FDA) for restylane kysse, a novel hyaluronic acid filler developed to enhance lip volume and reduce wrinkles around the mouth area. Additionally, Calcium hydroxylapatite (CaHA) is predicted to grow at fastest CAGR during the forecast period owing to the safety features, rising research & development activities in medical aesthetic sector and surge in launch of new products.
By Product, Biodegradable was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the expanded uses of biodegradable goods for aesthetic purposes, increasing product approvals, growing research & development activities, and rising launch of new products. For instance, in March 2022, Israeli-based aesthetic company, Hallura Ltd., reported positive topline outcomes from their European clinical trial involving their advanced hyaluronic acid dermal filler developed with the proprietary BiOLinkMatrix platform. The clinical trial evaluated the filler's safety and efficacy for three different uses: lip enhancement, correction of nasolabial folds, and cheek augmentation. Additionally, Non-biodegradable is predicted to grow at fastest CAGR during the forecast period owing to the rising research & development activities and growing technological advancements.
By Application, Wrinkle correction treatment was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the increasing demand for aesthetic procedures and surge in launch of new products. For instance, in January 2022, Teoxane's RHA Redensity has received approval from the U.S. FDA for its application in diminishing facial lines and wrinkles. Additionally, Lip enhancement is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for aesthetic improvements for lips and rising adoption of minimally invasive procedures.
By End-user, Specialty and dermatology clinics was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the surge in number of aesthetic procedures conducted in specialty & dermatology clinics, growing number of specialists offering face aesthetics care in dermatological offices, and increasing collaborations within market players. For instance, in June 2022, CAVENDISH CLINIC has collaborated with John Lewis Plc to offer aesthetic and beauty treatments, such as fillers, botulinum toxin, and CoolSculpting. These services will be made available at various John Lewis stores throughout the United Kingdom. Additionally, Hospitals is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare expenditure by governments, increasing prevalence of skin condition such as acne, hyperpigmentation, stretch marks, & scars, and rising number of patients visiting to the hospitals for cosmetic surgeries.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in number of hyaluronic acid procedures, rising product approvals for dermal fillers, presence of dermal filler industry, growing technological advancements in medical aesthetic sector, and increasing product approvals. For instance, in August 2022, AbbVie Inc. obtained approval from the U.S. FDA for JUVÉDERM VOLUX XC, a product designed to enhance the definition of the jawline in adult patients. This approval has allowed the company to expand its product lineup and uphold its position in the market. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing geriatric female populations, increasing awareness among young population regarding aesthetic procedures, rising healthcare expenditure, surge in introduction of innovative products within the region, and growing product approvals by regulatory bodies. For instance, in April 2020, Galderma revealed that the National Medical Products Administration of China (NMPA) has granted approvals for three of its products: Restylane Vital, Restylane Lidocaine, and Restylane Lyft Lidocaine. This development has led to the broadening of Restylane's product offerings in the Chinese market.
Surge in launch of innovative products by leading market players is predicted to boost the market growth during the forecast period. For instance, in February 2022, Medical aesthetics company, Merz Aesthetics, has introduced the Radiesse (+) Lidocaine injectable implant designed for deep injections to address the issue of moderate to severe loss of jawline contour in adults aged 21 and above.
By Type, Hyaluronic acid (HA) was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the growing adoption of dermal fillers by all age groups, increasing awareness about benefits of non-invasive aesthetic procedure, and rising approvals of technologically advanced products by regulatory bodies. For instance, in May 2020, Galderma, a pharmaceutical and dermatology company, has received approval from the U.S. Food & Drug Administration (FDA) for restylane kysse, a novel hyaluronic acid filler developed to enhance lip volume and reduce wrinkles around the mouth area. Additionally, Calcium hydroxylapatite (CaHA) is predicted to grow at fastest CAGR during the forecast period owing to the safety features, rising research & development activities in medical aesthetic sector and surge in launch of new products.
By Product, Biodegradable was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the expanded uses of biodegradable goods for aesthetic purposes, increasing product approvals, growing research & development activities, and rising launch of new products. For instance, in March 2022, Israeli-based aesthetic company, Hallura Ltd., reported positive topline outcomes from their European clinical trial involving their advanced hyaluronic acid dermal filler developed with the proprietary BiOLinkMatrix platform. The clinical trial evaluated the filler's safety and efficacy for three different uses: lip enhancement, correction of nasolabial folds, and cheek augmentation. Additionally, Non-biodegradable is predicted to grow at fastest CAGR during the forecast period owing to the rising research & development activities and growing technological advancements.
By Application, Wrinkle correction treatment was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the increasing demand for aesthetic procedures and surge in launch of new products. For instance, in January 2022, Teoxane's RHA Redensity has received approval from the U.S. FDA for its application in diminishing facial lines and wrinkles. Additionally, Lip enhancement is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for aesthetic improvements for lips and rising adoption of minimally invasive procedures.
By End-user, Specialty and dermatology clinics was the highest revenue-grossing segment in the global dermal fillers market in 2022 owing to the surge in number of aesthetic procedures conducted in specialty & dermatology clinics, growing number of specialists offering face aesthetics care in dermatological offices, and increasing collaborations within market players. For instance, in June 2022, CAVENDISH CLINIC has collaborated with John Lewis Plc to offer aesthetic and beauty treatments, such as fillers, botulinum toxin, and CoolSculpting. These services will be made available at various John Lewis stores throughout the United Kingdom. Additionally, Hospitals is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare expenditure by governments, increasing prevalence of skin condition such as acne, hyperpigmentation, stretch marks, & scars, and rising number of patients visiting to the hospitals for cosmetic surgeries.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in number of hyaluronic acid procedures, rising product approvals for dermal fillers, presence of dermal filler industry, growing technological advancements in medical aesthetic sector, and increasing product approvals. For instance, in August 2022, AbbVie Inc. obtained approval from the U.S. FDA for JUVÉDERM VOLUX XC, a product designed to enhance the definition of the jawline in adult patients. This approval has allowed the company to expand its product lineup and uphold its position in the market. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing geriatric female populations, increasing awareness among young population regarding aesthetic procedures, rising healthcare expenditure, surge in introduction of innovative products within the region, and growing product approvals by regulatory bodies. For instance, in April 2020, Galderma revealed that the National Medical Products Administration of China (NMPA) has granted approvals for three of its products: Restylane Vital, Restylane Lidocaine, and Restylane Lyft Lidocaine. This development has led to the broadening of Restylane's product offerings in the Chinese market.
Segmentation: Dermal Fillers Market Report 2022 - 2033
Dermal Fillers Market Analysis & Forecast by Type 2022 - 2033 (Revenue USD Bn)
- Calcium Hydroxylapatite (Caha)
- Poly-L-Lactic Acid
- Hyaluronic Acid (HA)
- Fat Filler
- PMMA (Poly Methyl Methacrylate)
- Others
Dermal Fillers Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Non-Biodegradable
- Biodegradable
Dermal Fillers Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Wrinkle Correction Treatment
- Restoration Of Volume/Fullness
- Lip Enhancement
- Scar Treatment
- Others
Dermal Fillers Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Hospitals
- Specialty And Dermatology Clinics
- Others
Dermal Fillers Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Dermal Fillers Market: Type Estimates & Trend Analysis
8. Dermal Fillers Market: Product Estimates & Trend Analysis
9. Dermal Fillers Market: Application Estimates & Trend Analysis
10. Dermal Fillers Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Dermal Fillers Market
13. Europe Global Dermal Fillers Market
14. Asia Pacific Global Dermal Fillers Market
15. Latin America Global Dermal Fillers Market
16. MEA Global Dermal Fillers Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Teoxane Laboratories
- Galderma SA
- Bioxis pharmaceutical
- Merz Pharma GmbH and Co. KGaA
- Revance Therapeutics
- Cutera Inc
- Elan aesthetics Inc
- AbbVie Laboratories
- Sinclair Pharma
- Vital Esthetique Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 6.42 Billion |
| Forecasted Market Value ( USD | $ 15.5 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
